Education, Science, Technology, Innovation and Life
Open Access
Sign In
  1. Home
  2. Journals
  3. MEDS Chinese Medicine
  4. Vol 5, Issue 9, 2023

Study on the law of TCM medication for for mild and medium-sized coronavirus pneumonia based on an ancient doctor case cloud platform

Download as PDF

DOI: 10.23977/medcm.2023.050901 | Downloads: 6 | Views: 358

Author(s)

Yuying Cui 1, Wei He 1

Affiliation(s)

1 Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712046, China

Corresponding Author

Wei He

ABSTRACT

The aim of this study was to analyze the medication rules of traditional Chinese medicine for mild as well as common type novel coronavirus pneumonia using the ancient doctor case cloud platform, and to provide a reference for clinical practice.We used computers to search CNKI, Wanfang, Wipe, PubMed, and Web of science databases for clinical randomized controlled trials of Chinese medicine in the treatment of mild and ordinary novel coronavirus pneumonia, extracted effective data into Excel tables and established a database of Chinese medicine prescriptions. With the help of the "data mining" function module of the ancient and modern medical record cloud platform (V2.3.5), we realized the analysis of drug frequency, taste, meridian tropism, clustering, and core prescriptions.Result display the study included 59 literatures and 87 TCM prescriptions involving 154 drugs with a total frequency of 1091 times, of which the high-frequency drugs included liquorice, scutellaria baicalensis, bitter almond, ephedrine and Atractylodes macrocephala et al. The medicinal four gases dominated by warm, cold, and clam, and five tastes are involved mainly including simba, bitterness, and gump; The warp reduction of medicines mainly involves the lungs, stomach, and spleen; The syndromes mainly involve dampness heat closed lung syndrome, cold dampness closed lung syndrome, dampness toxin closed lung syndrome; The cluster analysis results showed that the top 20 drugs in descending order of applied frequency could be classified into three major clusters; Complex network analysis revealed that traditional Chinese medicine treatments for mild as well as common forms of new crown pneumonia were prescribed with licorice, ephedra, scutellaria baicalensis, Pinellia ternata, gypsum, bitter almond, and radix bupleuri as core prescriptions.Traditional Chinese medicine treatment of mild as well as common forms of new coronavirus pneumonia is based on dampness dissolving table, clearing heat, eliminating phlegm, and antiasthma, and on toning yuan Qi, the therapeutic drugs are mostly selected on the basis of simba and bitterness products, ascribing the lungs and spleen to most drugs, and the method of deep inclusion and invigorating evil and Fuzheng.

KEYWORDS

COVID-19; drug use pattern; data mining

CITE THIS PAPER

Yuying Cui, Wei He, Study on the law of TCM medication for for mild and medium-sized coronavirus pneumonia based on an ancient doctor case cloud platform. MEDS Chinese Medicine (2023) Vol. 5: 1-9. DOI: http://dx.doi.org/10.23977/medcm.2023.050901.

REFERENCES

[1] Ping Y H, Yeh H, Chu L W, et al. The traditional Chinese medicine formula jing guan fang for preventing SARS-CoV-2 infection: from clinical observation to basic research [J]. Frontiers in pharmacology, 2022, 13:744439. 
[2] Lee D Y W, Li Q Y, Liu J, et al. Traditional Chinese herbal medicine at the forefront battle against COVID-19: Clinical experience and scientific basis[J]. Phytomedicine, 2021, 80:153337. 
[3] Huang W, Rao YL, Sun QG, et al. To explore the rules of traditional Chinese medicine (TCM) medication of 340 cases of COVID-19 based on data mining[J]. Journal of Hainan Medical College, 2020, 26(12):881-888+894. 
[4] Li ZY, Hao EW, Li H, et al. The pharmacological effects of licorice compatibility application and mechanism analysis [J]. Chinese Journal of Experimental Medicine, 2022, 28(14):270-282. 
[5] Gong FP, Zheng M. The chemical components and pharmacological effects of radix scutellariae[J]. Journal of Rational Use of Drugs in Clinical Practice, 2021, 14(34):176-178. 
[6] Ma C, Peng C, Li XR, et al. Research progress on chemical components and pharmacological activities of Pataglio rugosa [J]. Journal of Chengdu University of Traditional Chinese Medicine, 2020, 43(1):72-80. 
[7] Zhao L, Zhang C, Pan QQ, et al. Studies on chemical constituents and pharmacological activities of Pinellia pinellia [J]. Guangzhou Chemical Industry, 2012, 50(8):15-17+26. 
[8] Zhuang HY, Fang M, Wang YM, et al. Overview of herbal literature, pharmacology and clinical research on the prevention and treatment of epidemic diseases of Atractylodes atractylodes [J]. China Pharmaceutical Industry, 2020, 29 (21): 1-4. 
[9] Li YY, Lei GP, Dong S, et al. Research progress of modern pharmacological action of Bupleurum [J]. Hainan Medical College, 2012, 28(22):1748-1754. 
[10] Zhao Y, Zhang Z, Gao WH, et al. Study on the mechanism of modified Maxing-Yigan decoction against COVID-19 based on network pharmacology [J]. Hunan Journal of Traditional Chinese Medicine, 2021, 37(6):156-163. 
[11] Tong XL, Li XY, Zhao LH, et al. Prevention and treatment strategies of novel coronavirus pneumonia with traditional Chinese medicine from the perspective of "cold-damp epidemic" [J]. Journal of Traditional Chinese Medicine, 2020, 61(6):465-470+553. 
[12] Jin L, Gu BJ, Li CZ, et al. Research on the relationship between cold and hot properties of traditional Chinese medicine and its modern pharmacological effect [J]. Asia-pacific Traditional Medicine, 2020, 16(6):161-163. 
[13] Xu XL, Zhang T, Chen YH. Analysis of CT signs of novel coronavirus pneumonia [J]. Traffic Medicine, 2020, 34(2): 112-114. 
[14] Zhao C, Zhang XG, Chen CJ, et al. Maxingshigan Decoction can improve lung and colon tissue damage caused by influenza virus infection through JAK1/2-STAT1 signaling pathway[J]. China Journal of Chinese Materia Medica, 2022, 47(19):5306-5315.

Subscription
E-Mail Alert
Most popular papers
Call for Special Issue
Publication Ethics & OA Statement
Plagiarism Policy
Contact Us
Downloads: 4235
Visits: 167847

Sponsors, Associates, and Links

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.